323 |
I've invested in OREX before - and it went up to |
tommyschenck |
11/29/2012 4:55:30 PM |
322 |
and a $386,000,000 market cap |
Hike |
11/29/2012 3:47:05 PM |
321 |
I totally agree.....with all the different |
Couch |
11/29/2012 3:44:56 PM |
320 |
Its amazing isn't it. If anyone wants to know why |
tangerine |
11/29/2012 3:36:29 PM |
318 |
Naltrexone will be a big generic earner on it's |
steges |
11/29/2012 3:23:00 PM |
317 |
I read about this one in doing due diligence on |
tangerine |
11/29/2012 3:21:30 PM |
316 |
Something else from my hospital today: |
steges |
11/29/2012 3:17:39 PM |
315 |
Steges nice work there with Keating! You see his |
Couch |
11/29/2012 1:38:22 PM |
314 |
They have a lot of good things going for them. |
steges |
11/29/2012 11:15:32 AM |
313 |
Nice job Steges!!! I do wonder sometimes if Elite |
tangerine |
11/29/2012 11:08:21 AM |
312 |
Right -particularly with the same examiner, |
steges |
11/29/2012 10:58:14 AM |
311 |
I think it is. They submitted the revised claims |
tangerine |
11/29/2012 10:49:04 AM |
310 |
I thought this was a slam dunk given the previous |
steges |
11/29/2012 10:41:52 AM |
309 |
His declaration has been there for a long time I |
tangerine |
11/29/2012 10:30:53 AM |
308 |
What do you make of the David Erkoboni "Oath and |
steges |
11/29/2012 10:22:05 AM |
307 |
Yes it sure would. With everything else we have |
ryan g |
11/28/2012 10:10:35 PM |
306 |
Well the inventor of the technology Atul Mehta |
Couch |
11/28/2012 10:09:03 PM |
305 |
The way I view it is that we pretty much need |
ryan g |
11/28/2012 10:02:24 PM |
304 |
I think that is the idea. They could probably |
tangerine |
11/28/2012 9:17:21 PM |
303 |
Meaning that when this patent is allowed...this |
Couch |
11/28/2012 9:00:35 PM |
302 |
I think the first one gives them sufficient |
tangerine |
11/28/2012 8:50:01 PM |
301 |
Seems like the first one went through pretty |
ryan g |
11/28/2012 8:38:21 PM |
300 |
It is going to happen, just a matter of how it |
tangerine |
11/28/2012 8:25:59 PM |
299 |
I wouldn't mind getting another patent approved |
ryan g |
11/28/2012 8:03:17 PM |
298 |
I appreciate that Socius must believe their |
Couch |
11/28/2012 6:58:36 PM |
297 |
Took a few more minutes to review today's patent |
tangerine |
11/28/2012 6:37:20 PM |
296 |
If you add 10% to the common, in theory the value |
tangerine |
11/28/2012 6:25:45 PM |
295 |
That is why I am raising my concerns to discuss |
Couch |
11/28/2012 6:13:15 PM |
294 |
Patent update. Looks like at first glance the |
tangerine |
11/28/2012 4:53:45 PM |
292 |
If the stock is bought at .10 and the pps is |
tangerine |
11/28/2012 3:48:59 PM |
291 |
It still add shares to the float. You are correct |
Couch |
11/28/2012 3:42:16 PM |
289 |
These prices are really an insult to what the |
ryan g |
11/28/2012 1:35:48 PM |
288 |
Short covering is my best guess at that one. The |
tangerine |
11/28/2012 12:16:08 PM |
287 |
Notice much larger bids accumulating. I would |
g2 |
11/28/2012 11:19:29 AM |
286 |
If they are buying shares at .10 I don't |
tangerine |
11/28/2012 10:12:52 AM |
285 |
For my taste.....you sell Novel for the 5-8 |
Couch |
11/28/2012 8:17:42 AM |
284 |
The ANDAs and 505B2 will require much cheaper BE |
tangerine |
11/27/2012 10:24:35 AM |
283 |
With no debt and 5M+ in the bank there is no need |
JPC7330 |
11/27/2012 10:11:08 AM |
282 |
For the more expensive trials yes, I think they |
ryan g |
11/27/2012 10:01:11 AM |
281 |
I think they will def move forward with a |
g2 |
11/27/2012 9:51:56 AM |
279 |
When you say pay for trials, is that with or |
NASDAQ2020 |
11/27/2012 9:43:15 AM |
278 |
I agree Couch. Sell Novel for hopefully 5-10 |
mrwrn2010 |
11/27/2012 3:28:52 AM |
277 |
For the extended release 24 hour Oxy and perhaps |
tangerine |
11/26/2012 6:53:08 PM |
276 |
You raised another point worth tying in |
Couch |
11/26/2012 6:48:56 PM |
275 |
I'd prefer they sell the Novel stake and pay off |
ryan g |
11/26/2012 5:11:15 PM |
274 |
Profititable years or Qs? I believe that these |
tangerine |
11/26/2012 4:13:27 PM |